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Abstract 
The process of anesthesia is nonlinear with time delay and also there are some constraints which have to be 
considered in calculating administrative drug dosage. We present an Extended Kalman Filter (EKF) observer to 
estimate drug concentration in the patient’s body and use this estimation in a state-space based Model of Predictive 
Controller (MPC) for controlling the depth of anesthesia. Bispectral Index (BIS) is used as a patient consciousness 
index and propofol as an anesthetic agent. Performance evaluations of the proposed controller, the results have been 
compared with those of a MPC controller. The results demonstrate that state-space MPC including the EKF estimator 
for controlling the anesthesia process can significantly increase the robustness in encountering patients' delay 
deviations in comparison with the MPC. 
© 2011 Published by Elsevier Ltd. 
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1. Introduction
Nowadays, anesthesia is one of the essential components of any surgical operation [1]. 
Anesthesiologists always want to be assured of the proper level of the patients’ anesthesia. Automatic 
control methods are advantageous for this purpose which aims are administered the appropriate drug 
dosage to keep the patient on an adequate level of anesthesia. There should be an index which can be a 
good indicator of the depth of anesthesia. Among all the indexes which have been introduced in these 
years, BIS is one of the best [2] and we consider it as a deep index of anesthesia in this paper. 
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Recently, several methods have been introduced for controlling the Depth of Anesthesia (DOA) [3]. 
Fixed gain controllers such as P, PI, and PID strategies can perform well when used in clinical therapy and 
under certain conditions [4,5], on the other hand, It can lead poor performances because of the large 
variability between subjects and the delay which exists in the patient’s model. The process of anesthesia is 
nonlinear with time delay and there are also some constraints which have to be considered in calculating 
administrative drug dosage. So, the MPC controller is a good choice for these kinds of systems. In [5] and 
[6], they used MPC for controlling the DOA. In [5], physiological model and also MAP are used as a sign 
of DOA. But, it seems that using other types of signals such as BIS or Auditory Evoked Potentials (AEP) 
are more valid for showing DOA level [7]. In [6] MPC with PK-PD model as a controller and BIS as 
hypnotic index are used. The results of this group were much better than those of [5], but since they used 
only the BIS as a feedback signal, their method did not have a good performance against disturbance and 
noise. 
A lot of control methods described above have been used for controlling the DOA, but none of them 
pay attention to delay difference between patients. Whereas the delay of the patient is one of the individual 
patient’s features and generally not obvious, the controller which endures larger difference delay, is more 
preferable. On the other hand, for controlling the DOA none of the methods has used state-space model. 
Since in the state feedback technique more information is used in feedback way, a designer has more 
freedom and the controller has a better performance. However, in this method all states may not be 
available. In our problem, there is no a direct access to the drug concentration in the patient’s body, and 
therefore, the presence of an observer is essential.   
In this paper, first, the EKF is used as a nonlinear observer in order to estimate the drug constraint in 
the patient’s body and then, this observer is used in a state space based model predictive controller (MPC) 
for controlling the DOA which is evaluated by BIS. The proposed model is better comparison with that of 
the previous researches because it considers some individual parameters which will be introduced in 
section 2. In section 3 we explain the strategy and design of MPC with EKF algorithm. The result of the 
simulations is presented in section 4 and conclusions are reported in section 5. 
2. Pharmacokinetic-Pharmacodynamic Model 
In this section, we introduce a model of the BIS response to propofol infusion. The model is a series 
connection of two elements: a pharmacokinetic model and a Pharmacodynamic model. Pharmacokinetic 
models describe the dynamics of drug concentration in human body. We use a pharmacokinetic model 
based on the population of pharmacokinetic model was proposed by Schüttler and Ihmsen [8] because this 
model incorporates the individual patient’s parameters. 
Fig. 1. Pharmacokinetics-Pharmacodynamic compartmental model with the effect site [9]. 
The original version of the Schüttler–Ihmsen model is given as equation (1). Here, xi is the 
concentration of propofol in compartments i; compartments 1, 2, and 3 correspond, respectively, to the 
central, shallow peripheral and deep peripheral compartments (Fig. 1). In addition u is the infusion rate of 
propofol, and Vi are the clearance and volume of compartment i respectively, given as functions of the 
patient’s age and weight [6].  
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An effect compartment is attached to the central compartment of the PK model to capture the complete 
response of the drug on specific endpoints (Fig. 1). It is assumed that the effect compartment receives a 
small mass of drug at a rate directly proportional to the central compartment drug concentration, which 
does not affect other time constants of the model. In steady-state, the concentration of this part can be 
related to the plasma concentration by the equation below: 
( )e 1 ed u(t) kdt
ex x x= −
( )
(2) 
Where x1 and xe are the plasma concentrations and the concentration in the effect compartment, 
respectively [9]. 
A Pharmacodynamic model describes the relationship between the propofol concentration in the effect 
site compartment and the BIS. We use the sigmoid model Emax because it is widely accepted in 
Pharmacodynamic studies of propofol. This model is given as 
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(3) 
Where BIS(t), BIS0 are the current and awakening BIS, EC50 is the concentration of the drug at which half 
of the maximum achievable effect is observed in the patient, γ is the Hill coefficient [6]. According to [8], 
the PK model is obtained by knowing the age, weight of the patient, the sampling site and also the type of 
administration. For PD parameters we use the data gathered in [3] for 44 patients with different ages. 
3. Depth of Anesthesia Control System 
3.1. Extended Kalman Filter (EKF) 
We cannot have access to the drug concentration in the patient’s body; this problem can be solved by 
using an observer. An observer is integrated knowledge of plant and measurement dynamics, statistics of 
the process and measurement noise, and an initial condition, to yield an estimate of the state of the system. 
The well-known KF is an optimal estimator for linear systems [10]. In the sense of minimum error 
covariance, under the assumption that the plant and measurement dynamics are linear and known, the 
process and measurement noise are zero-mean Gaussian random processes and uncorrelated with each 
other, and the initial state of the system is a Gaussian random vector with known mean and covariance. The 
EKF is an extension of the original filter to nonlinear systems. Although the EKF has been a popular 
choice among researchers, the performance of the filter will depend upon the accuracy of the linear 
approximation. So, the linearization PD model around EC50 was done at each stage of state approximation. 
3.2. Model-Predictive Controller (MPC) 
Manual control by anesthesiologist can be tedious, imprecise, time consuming and sometimes of poor 
quality, depending on his skills and judgment. Under dosing in a patient may cause pain and awareness 
during surgery, while overdosing may result in delayed recovery from anesthesia and may also result in 
respiratory and cardiovascular collapse. Closed-loop control may be improved the quality of drug 
administration, lessening the dependence of patient outcome on the skills of the anesthesiologist [7]. As 
anesthesia contains delay and there are also some constraints which should be considered on the infusion 
and the rate of drug infusion it seems that the MPC controllers belong to MPC is a good choice. The 
controller computes the vector of controls over prediction horizon by using optimization of a function:  
( ) ( ) $ ( ) ( ) ( ) (u2
1
NN 2
1 2 u
j N j 1
J N N N j y t j t w j j u t j 1, ,
= =
⎡ ⎤ ) 2⎡ ⎤= δ + − + + α Δ + −⎣ ⎦⎣ ⎦∑ ∑ (4) 
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( ) ( )
Where N1 and N2 are the minimum and maximum costing horizon, Nu is the control horizon, w is the 
future set-point, α(j) and δ(j) are the weighting sequences .The aim of predictive control is to keep the 
output as near as w, for this purpose (5) should be minimized by considering the constraints defined in (5). 
For solving equation (4) subject to the following constraints, MATLAB quadratic program is used. 
(5) g0 2 u t j 1 0 2 0 u t j 1 300
kg min
. . ;
.
μ
− ≤ Δ + − ≤ ≤ + − ≤
Considering these constraints in controlling the process is necessary because first of all, the drug input 
cannot be negative and on the other hand the maximum effect of the drugs is defined since the 
administration of a drug more than a special amount is useless [9]. 
4. Simulation Results 
The PK-PD model was used for designing the controller. The patient’s specifications used in these 
simulations extracted from [3] and are given in Table 1.  
Table 1. Patients' specifications [3] 
Parameter V1 (L) k10 (s-1) k21 (s-1) k12 (s-1) k31 (s-1) k13 (s-1) ke0 (s-1) Td (s) BIS0 γ EC50  (μg/mL)
Nominal 9.5855 0.0028 8.495e-4 0.0042 6.182e-5 0.0017 39e-3 12.9 100 2 3.3
Patient 1 10.450 0.0029 8.506e-4 0.0044 6.659e-5 0.0018 24.8 e-3 4 100 2 2.7
Patient 2 8.947 0.0027 8.485e-4 0.0042 5.810e-5 0.0017 83.1 e-3 29 100 2.3 4
A nominal model was considered by using average data and the design of controllers (state-space MPC 
couple with EKF and MPC) have been done based on this nominal patient model. The simulation results of 
both controllers are shown in Fig. 2 and Fig. 3.  
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Fig. 2. Simulation results of the MPC controller. The upper 
panel shows the BIS , and the lower panel shows the infusion 
rate of the propofol for the nominal model (solid line), Patient 1 
(dashed line) and Patient 2 (dotted line).
Fig. 3. Simulation results of the state-space MPC including the 
EKF. The upper panel shows the BIS , and the lower panel 
shows the infusion rate of the propofol for the nominal model 
(solid line), Patient 1 (dashed line) and Patient 2 (dotted line).
The simulations show, the methods have an acceptable performance. The amount of administered drug 
in purposed method is less than that of MPC controller, although the MPC controller shows less 
undershoots. If there is difference between the patient delay and nominal delay (Fig. 4 and Fig. 5) purposed 
method has better performance.  
Table2. Maximum range of tolerable delay for controllers  
Controller Tolerable delay (Sec)  
MPC 30 
State-space MPC including EKF 45
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While the difference of delay is less than values in Table 2, the settling time slightly increases, but BIS 
stays in the acceptable bound. As mentioned in Table 2, purposed method can cover more delay difference 
than MPC controller. 
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Fig. 4. Closed loop response of the anesthesia process in the 
nominal condition (solid line) and in presence of maximum 
tolerable delay  (dashed line) and  no delay (dotted line) for 
MPC controller. 
Fig. 5. Closed loop response of the anesthesia process in the 
nominal condition (solid line) and in presence of maximum 
tolerable delay  (dashed line) and  no delay (dotted line) for the 
state-space MPC including the EKF.
5. Conclusion 
In this paper, the DOA was controlled by a model predictive controller. In this system the BIS was 
considered as the index of consciousness and propofol was considered as an anesthetic drug. We used EKF 
as an observer for the estimation of drug in the patient’s body. When there isn’t any uncertainty, 
simulations have shown that purposed method have similar performance with MPC. The results showed 
that the state-space MPC including the EKF estimator for controlling the anesthesia process can 
significantly increase the robustness in encountering patients' delay deviations in comparison with the 
MPC. Whereas the delay of the patient is one of the individual patient’s feature and generally not obvious, 
the controller which endures larger difference from nominal case, is more preferable. 
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